A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome

NCT00420459 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Indiana University